Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fox Chase Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014173
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancers, and others. It offers medical imaging services, which include digital mammography, MRI, CT scan, digital X-ray, PET scan, nuclear medicine and ultrasound in the areas of radiology, interventional radiology and nuclear medicine. Fox Chase’s clinical care services include adrenal mass, bladder cancer, cervical cancer, esophageal cancer, and brain and spinal tumors, among others. The center conducts clinical research with various programs in cancer prevention, detection, survivorship, and community outreach. Fox Chase is headquartered in Philadelphia, Pennsylvania, the US.

Fox Chase Cancer Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fox Chase Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ReproCELL and Fox Chase Cancer Center Enter into Partnership 10
Erytech Pharma Enters into Research Agreement with Fox Chase Cancer Center 11
Morphotek Enters into Research Agreement with Fox Chase Cancer Center 12
Ascend Biopharma Enters into R&D Agreement with Fox Chase Cancer Center 13
Accutest Research Labs Enters into Agreement with Fox Chase Cancer Center 14
Chang’An Hospital Enters Into Agreement With Fox Chase Cancer Center 15
Oncobiologics Enters Into Co-Development Agreement With Fox Chase Cancer Center 16
Ignite Institute, Fox Chase And Life Technologies Form Cancer Genome Institute 17
Fox Chase Cancer Center Enters Into Agreement With Life Technologies 18
Horizon Discovery Enters Into Joint Venture Agreement With Fox Chase Cancer 19
Licensing Agreements 20
AvidBiologics Enters into Agreement With YM BioSciences, NRC-BRI and Fox Chase Cancer Centre 20
Fox Chase Cancer Center – Key Competitors 21
Fox Chase Cancer Center – Key Employees 22
Fox Chase Cancer Center – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Strategy And Business Planning 24
May 23, 2017: REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India 24
Legal and Regulatory 25
Oct 05, 2016: Fox Chase Cancer Center Designated as a National Pancreas Foundation Center 25
Aug 22, 2016: National Cancer Institute Renews Fox Chase Cancer Center’s Comprehensive Designation 26
Government and Public Interest 27
Jul 13, 2017: Several Fox Chase Cancer Center and Temple Health Research Projects Awarded Funding Support Grants 27
Nov 07, 2016: Fox Chase Researchers Unlock Previously Inaccessible DNA Regions, Creating a Path for New Cancer Drug Discovery 28
Aug 01, 2016: UCLA researchers report high-dose radiation therapy as effective as surgery for aggressive prostate cancer 29
Jul 06, 2016: Researchers from Fox Chase Cancer Center Identify ERC33-MYC as a Target in Pancreatic Cancer 30
May 19, 2016: New Programming Approach Produces Alloreactive T Cells That Destroy Leukemia Without Added Risk of GvHD 31
May 01, 2016: Newly Discovered Cause of Drug Resistance Could Improve Outcomes for Breast and Ovarian Cancer 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Key Facts 2
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fox Chase Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fox Chase Cancer Center, Deals By Therapy Area, 2011 to YTD 2017 8
Fox Chase Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ReproCELL and Fox Chase Cancer Center Enter into Partnership 10
Erytech Pharma Enters into Research Agreement with Fox Chase Cancer Center 11
Morphotek Enters into Research Agreement with Fox Chase Cancer Center 12
Ascend Biopharma Enters into R&D Agreement with Fox Chase Cancer Center 13
Accutest Research Labs Enters into Agreement with Fox Chase Cancer Center 14
Chang'An Hospital Enters Into Agreement With Fox Chase Cancer Center 15
Oncobiologics Enters Into Co-Development Agreement With Fox Chase Cancer Center 16
Ignite Institute, Fox Chase And Life Technologies Form Cancer Genome Institute 17
Fox Chase Cancer Center Enters Into Agreement With Life Technologies 18
Horizon Discovery Enters Into Joint Venture Agreement With Fox Chase Cancer 19
AvidBiologics Enters into Agreement With YM BioSciences, NRC-BRI and Fox Chase Cancer Centre 20
Fox Chase Cancer Center, Key Competitors 21
Fox Chase Cancer Center, Key Employees 22
Fox Chase Cancer Center, Other Locations 23
Fox Chase Cancer Center, Joint Venture 23

★海外企業調査レポート[Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Opthea Ltd (OPT):医療機器:M&Aディール及び事業提携情報
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • Dominion Energy Inc:企業の発電所・SWOT分析2018
    Dominion Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …
  • Oaktree Capital Group LLC:企業の戦略・SWOT・財務情報
    Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Associated Alcohols & Breweries Limited.:企業の戦略・SWOT・財務情報
    Associated Alcohols & Breweries Limited. - Strategy, SWOT and Corporate Finance Report Summary Associated Alcohols & Breweries Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Adaptive Biotechnologies Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conductin …
  • Kier Group plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • International Flavors & Fragrances Inc.:企業の戦略・SWOT・財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Teleflex Incorporated:戦略・SWOT・企業財務分析
    Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報
    Summary Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early d …
  • Whirlpool Corporation (WHR):企業の財務・戦略的SWOT分析
    Whirlpool Corporation (WHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TYI 2011 Ltd:企業の戦略的SWOT分析
    TYI 2011 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Inner Mongolia Yili Industrial Group Co Ltd:企業の戦略・SWOT・財務情報
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Hero AG:企業の戦略・SWOT・財務分析
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報
    Summary Ovid Therapeutics Inc (Ovid Therapeutics) is a bio-pharmaceutical company which identifies, discovers, and develops medicines for neurological disorders. The company’s pipeline products are indicated for diseases such as Angelman Syndrome and Fragile X Syndrome. It develops, assess, commerci …
  • Petoro AS-石油・ガス分野:企業M&A・提携分析
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Italian Coffee Holdings Ltd:企業の戦略・SWOT・財務分析
    Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆